Ticlopidine-associated thrombotic thrombocytopenic purpura.
Thrombotic thrombocytopenic purpura is a rare complication of ticlopidine treatment. This syndrome has been reported to occur typically within the first few weeks after the initiation of therapy. The authors describe a case of a 72-year-old woman in whom thrombotic thrombocytopenic purpura developed just 2 days after starting ticlopidine therapy for a new-onset ischemic stroke. The patient responded successfully to plasmapheresis. The authors are reporting this case to emphasize the unpredictable nature of the association between the drug and the disease, which necessitates careful hematologic monitoring.
Naseer
N
N
Divisions of General Internal Medicine, New York Medical College/Westchester Medical Center, Valhalla, New York 10595, USA.
Aijaz
A
A
Saleem
M A
MA
Nelson
J
J
Peterson
S J
SJ
Frishman
W H
WH
D000368:Aged; D005260:Female; D006801:Humans; D010975:Platelet Aggregation Inhibitors / Q000009:adverse effects*; D011697:Purpura, Thrombotic Thrombocytopenic / Q000139:chemically induced*; D013988:Ticlopidine / Q000009:adverse effects*; D017211:Treatment Failure
D010975:Platelet Aggregation Inhibitors; D013988:Ticlopidine